Milestone Pharmaceuticals Inc.

MIST · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$42-$60-$58-$43
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$6$10$9$7
Change in WC$4$1-$3$2
Other Non-Cash$3$2$0$0
Operating Cash Flow-$29-$46-$52-$33
Investing Activities
PP&E Inv.-$0-$0-$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$114-$137-$86-$15
Inv. Sales/Matur.$122$142$29$85
Other Inv. Act.$0$0$0$0
Investing Cash Flow$8$5-$57$70
Financing Activities
Debt Repay.$0$50$0$0
Stock Issued$27$0$3$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$5-$2$0$5
Financing Cash Flow$32$48$3$5
Forex Effect$0$0$0$0
Net Chg. in Cash$12$6-$107$42
Supplemental Information
Beg. Cash$14$8$114$72
End Cash$25$14$8$114
Free Cash Flow-$29-$47-$53-$33